Biopharma Company from West Coast to expand R&D Lab to Texas
Houston, TX – July 27, 2024 – Newcor is pleased to announce the successful sale of a 27,375 square foot, state-of-the-art tilt wall building located at the corner of Hufsmith-Kohrville and Spell Road, at the main entrance into the Tomball Business and Technology Park.
The facility has been purchased by an undisclosed biopharma company from the West Coast, which is expanding its operations to Texas. The building will be outfitted with lab space for Research and Development, Manufacturing, and Distribution.
“We are thrilled to have facilitated the sale of this exceptional property to such a prestigious company,” said Rob Banzhaf, Founder and CEO of Newcor. “This sale is a perfect example of The Newcor Flywheel in action, as it involved all facets of our three companies – Brokerage, Investment, and Development. We look forward to announcing more about the tenant and their tremendous benefit to the community at the appropriate time.”
After an in-depth market analysis, Newcor purchased this strategic site and broke ground on the building seven months ago. The facility was contracted and successfully closed within days of its completion, underscoring Newcor’s ability to add value and serve the market to fulfill unmet market demand. By aligning the building’s development with the specific needs of high-growth industries, Newcor not only attracted a prominent biopharma company but also reinforced the region’s appeal to innovative businesses, highlighting their expertise in driving economic growth.
For further details about this acquisition or to learn more about Newcor and its services, please contact:
Rob Banzhaf |
In case you couldn't find Mr. Deal-here he is ↓